REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
28/04/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
DIAGNOSTICS DEFINING THERAPY
ST13
US500000079259148Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Joi A. White Carr & Ferrell LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industry, science, photography, agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; reagents and reactants for non-medical purposes; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; acids, namely inorganic acids for industrial purposes; DNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring
Classe 5
Pharmaceutical and veterinary preparations and substances; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; enzymes for pharmaceutical, veterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; clinical diagnostics for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
Classe 10
Surgical, medical and veterinary apparatus and instruments; diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits containing diagnostic testing apparatus; point of care medical devices; screening kits in this class comprised of medical screening and testing apparatus for the diagnosis of disease, detection and/or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy
Classe 42
Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, and scientific research consulting in the field of genetics; genetic research; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services, namely, chemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services; custom design and development of biochemical assays; molecular diagnostics testing
Classe 44
Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to dna, genetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; diagnostic imaging for medical purposes and molecular medicine healthcare services
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
28/04/2025
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/08/2022
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/08/2022
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/08/2022
CHANGE OF NAME/ADDRESS REC'D FROM IB
13/08/2021
FINAL DECISION TRANSACTION PROCESSED BY IB
26/09/2020
FINAL DISPOSITION NOTICE SENT TO IB
06/09/2020
FINAL DISPOSITION PROCESSED
31/08/2020
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/07/2020
REGISTERED-PRINCIPAL REGISTER
28/04/2020
NOTIFICATION PROCESSED BY IB
14/02/2020
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/02/2020
PUBLISHED FOR OPPOSITION
11/02/2020
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/01/2020
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/01/2020
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/01/2020
APPROVED FOR PUB - PRINCIPAL REGISTER
07/01/2020
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/12/2019
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/12/2019
TEAS/EMAIL CORRESPONDENCE ENTERED
18/12/2019
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/12/2019
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/12/2019
REFUSAL PROCESSED BY IB
12/07/2019
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/06/2019
REFUSAL PROCESSED BY MPU
24/06/2019
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/06/2019
NON-FINAL ACTION WRITTEN
04/06/2019
APPLICATION FILING RECEIPT MAILED
01/06/2019
ASSIGNED TO EXAMINER
28/05/2019
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/05/2019
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/05/2019
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.